Abstract:Introduction: Structure-based drug design is a wide area of identification of selective inhibitors of a target of interest. From the time of the availability of three dimensional structure of the drug targets, mostly the proteins, many computational methods had emerged to address the challenges associated with drug design process. Particularly, drug-likeness, druggability of the target protein, specificity, off-target binding, etc., are the important factors to determine the efficacy of new chemical inhibitors. Objective: The aim of the present research was to improve the drug design strategies in field of design of novel inhibitors with respect to specific target protein in disease pathology. Recent statistical machine learning methods applied for structural and chemical data analysis had been elaborated in current drug design field. Methods: As the size of the biological data shows a continuous growth, new computational algorithms and analytical methods are being developed with different objectives. It covers a wide area, from protein structure prediction to drug toxicity prediction. Moreover, the computational methods are available to analyze the structural data of varying types and sizes of which, most of the semi-empirical force field and quantum mechanics based molecular modeling methods showed a proven accuracy towards analysing small structural data sets while statistics based methods such as machine learning, QSAR and other specific data analytics methods are robust for large scale data analysis. Results: In this present study, the background has been reviewed for new drug lead development with respect specific drug targets of interest. Overall approach of both the extreme methods were also used to demonstrate with the plausible outcome. Conclusion: In this chapter, we focus on the recent developments in the structure-based drug design using advanced molecular modeling techniques in conjunction with machine learning and other data analytics methods. Natural products based drug discovery is also discussed.

[Computational chemistry in structure-based drug design].

Advances in Computational Structure-Based Drug Design and Application in Drug Discovery.

Computational Methods for Structure-Based Drug Design Through System Biology.

Quantitative Structure–activity Relationship: Promising Advances in Drug Discovery Platforms

Computational approaches streamlining drug discovery

Structure-Based Drug Design Strategies and Challenges

Current Developments of Computer-Aided Drug Design

Towards Structure-Based Protein Drug Design

Structure-Based Approach For In-Silico Drug Designing

New trends in computational structure prediction of ligand-protein complexes for receptor-based drug design

Computer Modeling for Interaction of Ligands and Receptors and Their Applications in Drug Design

Recent Trends in Drug Design and Discovery

Molecular Docking and Structure-Based Drug Design Strategies

Computational Chemistry in Structure-Based Solute Carrier Transporter Drug Design: Recent Advances and Future Perspectives

Computational drug development for membrane protein targets

Structure-based drug design: From nucleic acid to membrane protein targets

Structural biology and bioinformatics in drug design: opportunities and challenges for target identification and lead discovery

COMPUTATIONAL METHOD FOR DRUG TARGET SEARCH AND APPLICATION IN DRUG DISCOVERY

A Guide to In Silico Drug Design

Sequence-based drug design as a concept in computational drug design

Structure-Based Virtual Screening of Chemical Libraries for Drug Discovery